Dr. Carol Sherman is a thoracic medical oncologist at the Hollings Cancer Center at the Medical University of South Carolina. Though she has experience treating other diseases and conditions, Dr. Sherman’s main interest is lung cancers. Dr. Sherman cares for patients at the Hollings multidisciplinary clinic, as well as other outpatient clinics and outreach clinics in South Carolina.
To expand her research efforts, Dr. Sherman participates in many clinical trials, also acting as an institutional principle investigator. Through her time at Hollings, Dr. Sherman has held the positions of Interim Chief of the Division of Hematology/Oncology and Medical Director of the Hollings Cancer Center.
Main Speciality: Internal Medicine, Internal Medicine: Medical Oncology
Other Interests & Specialties: Hematologic oncology, lung cancer, mesothelioma and thymic malignancies.
Certifications, Awards & Accolades: American Board of Internal Medicine Certifications for Internal Medicine and Medical Oncology, member of Data Safety Monitoring Committee, member of Protocol Review Committee, member of the Promotions and Tenure Committee
Education & Experience:
- Medical Degree from University of Massachusetts Medical School
- Residency for Internal Medicine at University of Massachusetts
- Fellowship for Hematology at University of Massachusetts
Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib. Journal of Thoracic OncologyFebruary 2015;10(2):232-236. doi: 10.1097/JTO.0000000000000455
The 1997 International Staging System for Non-Small Cell Lung Cancer: Have All the Issues Been Addressed? Chest. January 1999;115(1):242-248. doi: 10.1378/chest.115.1.242
- Mesothelioma Doctors
- Cancer Centers
- Treatment Near You
- Experimental Treatments
- Alternative Treatments
- Clinical Trials
- Caregiver Resources
- Treatment Costs